Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GobyMeds vs Heros Health

GobyMeds
Graded #140

Higher grade

vs+2.6000000000000085
Heros Health
Graded #194

Lower grade

The verdict

GobyMeds takes it — 68.9/100 to 66.3/100.

GobyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Affordable telehealth provider offering compounded semaglutide only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGobyMeds +7
67
60
Dose & formulationGobyMeds +11
75
64
Clinical oversightHeros Health +5
82
87
Labs & monitoringHeros Health +1
53
54
FulfillmentHeros Health +6
70
76
Contract termsGobyMeds +6
55
49
GobyMeds · left barHeros Health · right bar

The numbers

MetricGobyMedsHeros Health
WeighScore68.9/10066.3/100
GradeCC
Scorecard rank#140#194
Semaglutide$169/mo (all doses, compounded)$199/mo (compounded)
Tirzepatide$299/mo (all doses, compounded)$199/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
GobyMeds

Graded #140 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Heros Health

Graded #194 · C

Strengths

  • Compounded semaglutide and tirzepatide on a flat program price, not tiered by dose
  • Transparent pricing: $149 first month, then $199/mo (or $165/mo on the 3-month plan)
  • 90-day money-back guarantee on GLP-1 treatment
  • Dose adjustments at weeks 2, 4, and 8 included at no extra cost
  • Named board-certified physicians (Dr. Amber Patel, Dr. Scott Sanderson, Dr. Scott Nass)

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Specific 503A pharmacy partner is not named publicly
  • State coverage is stated inconsistently on the site (claims both 50 and 46 states)
  • No insurance billing — cash-pay only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard